Table 1 Clinico-pathological characteristics, viral DNA load and plasma concentration of miR-BART17 normalized with miR-cel-39 for samples from NPC patients
Patient | Gender/age | Origin | First occurrence (FO) or Relapse(R) | TNM | Histology | EBV DNA copy number/ml | miR BART17 copy number/ml |
|---|---|---|---|---|---|---|---|
1 | M/59 | France | FO | cT4N2M0 | NKUC | 1559 | 26 |
2 | M/43 | Morocco | R | rT0N0M1 | NKUC | 7065 | 148 |
3 | M/55 | Cambodia | FO | cT3N0M0 | NKUC | 28 | 1226 |
4 | M/40 | Algeria | FO | cT4N1M0 | NKUC | 325 | 8014 |
5 | M/61 | Algeria | FO | cT2N2M0 | NKUC | 466 | 279 |
6 | M/47 | China | FO | cT2N0M0 | NKUC | 0 | 4501 |
7 | F/34 | Sweden | FO | cT2N3aM1 | NKUC | 67 | 11087 |
8 | F/47 | Tunisia | FO | cT2N1M0 | NKDC | 0 | 739 |
9 | M/40 | North Africa | FO | cT1N3bM0 | NKUC | 40 | 8824 |
10 | M/51 | North Africa | FO | cT3N2M1 | NKUC | 1142 | 242506 |
11 | M/41 | Turkey | R | rTXN1M0 | KSCC | 79 | 128426 |
12 | M/49 | France | FO | cT3N1M0 | NKUC | 0 | 2725 |
13 | M/65 | France | R | rT2N3bM0 | NKUC | 0 | 448961 |
14 | M/58 | Tunisia | FO* | cT2N0M0 | NKUC | 351 | 589 |
15 | M/41 | Tunisia | FO* | cT3N2M0 | NKUC | 1475 | 4889 |
16 | F/49 | France | FO | cT2N2M0 | NKUC | 9 | 205985 |
17 | F/39 | Morocco | FO | cT4N1M0 | NKUC | 0 | 1080 |
18 | M/62 | Algeria | R* | rT4N0M0 | NKUC | 328 | 161 |
19 | M/66 | Algeria | R | rT0N2M0 | NKUC | 31 | 25788 |
20 | M/47 | Cameroon | R | rTXN2M1 | NKUC | 21 | 42 |
21 | M/58 | Cameroon | R* | cT2bN1M1 | NKUC | 8 | 3220 |
22 | M/60 | Morocco | R | rT1N2M0 | NKUC | 136 | 4401 |
23 | M/59 | Algeria | R | rT1NxM0 | NKUC | 0 | 2465 |
24 | M/58 | Algeria | FO* | cT1N3bM0 | NKUC | 20 | 11 |
25 | F/40 | France | R | rT0N0M1 | NKUC | 0 | 155002 |
26 | M/61 | Cameroon | R* | rT4N0M0 | NKUC | 0 | 19881 |